Integra Lifesciences Holdings (IART) Assets Average (2010 - 2026)

Integra Lifesciences Holdings has disclosed Assets Average across 17 years of filings, most recently posting $3.6 billion for Q2 2026.

• In Q2 2026, Assets Average fell 7.51% year-over-year to $3.6 billion; the TTM figure through Jun 2026 stood at $3.6 billion (down 7.51% YoY), while the FY2025 annual figure was $3.8 billion, down 2.3% from the prior year.
• Assets Average came in at $3.6 billion for Q2 2026 at Integra Lifesciences Holdings, down from $3.6 billion in the prior quarter.
• In the past five years, Assets Average ranged from a high of $4.1 billion in Q2 2024 to a low of $3.6 billion in Q2 2026.
• Average Assets Average over 5 years is $3.8 billion, with a median of $3.8 billion recorded in 2022.
• Year-over-year, Assets Average increased 8.41% in 2024 and slipped 11.25% in 2026.
• Over 5 years, Assets Average stood at $3.8 billion in 2022, then dropped by 2.28% to $3.8 billion in 2023, then grew by 7.74% to $4.1 billion in 2024, then decreased by 10.55% to $3.6 billion in 2025, then dropped by 1.48% to $3.6 billion in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $3.6 billion in Q2 2026, $3.6 billion in Q1 2026, and $3.6 billion in Q4 2025.